Cingulate Appoints Jennifer Callahan As Interim CEO; Names Jay Roberts Executive Chairman
Benzinga Newsdesk 1 year ago
News
Jennifer Callahan, Chief Financial Officer, appointed Interim CEOBoard member, Jay Roberts appointed Executive ChairmanKANSAS CITY, Kan., Aug. 15, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:CING) The Board of Directors of
Jennifer Callahan, Chief Financial Officer, appointed Interim CEO
Board member, Jay Roberts appointed Executive Chairman
KANSAS CITY, Kan., Aug. 15, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:CING) The Board of Directors of Cingulate Inc. ("Cingulate") announced that it has placed Chairman and Chief Executive Officer, Shane J. Schaffer, PharmD, on administrative leave in connection with ongoing legal matters unrelated to the company and its operations. In addition, Jennifer Callahan, Cingulate's Chief Financial Officer, has been appointed interim CEO to ensure business continuity and operational stability. Ms. Callahan will retain her responsibilities as Chief Financial Officer. Healthcare industry veteran and current Cingulate board member Jay Roberts has been appointed Executive Chairman, bringing decades of operational expertise to directly support the management team's strategic initiatives.